Study targets key molecule to reverse kidney damage in mice
Test likely to proceed to clinical trials BOSTON -- In findings that may lead to clinical trials of a promising new drug for kidney disease, researchers at Beth Israel Deaconess…
My Personal Biomedical Research Feed – Ralph Turchiano, CEO Alchepharma
Test likely to proceed to clinical trials BOSTON -- In findings that may lead to clinical trials of a promising new drug for kidney disease, researchers at Beth Israel Deaconess…
You must be logged in to post a comment.